GAIN Trial – Alzheimer’s Disease Research Study mild to moderate

  • STATUS
    Not Recruiting
  • End date
    Jan 31, 2022
Updated on 12 January 2021

Summary

The Memory Health Center at Summit Research Network, is enrolling participants in the GAIN clinical trial.  This trial will evaluate whether the investigational medication, COR388, is safe and can slow or stop the progression of Alzheimer’s by reducing the damage caused by a bacteria commonly associated with gum disease that can travel to the brain.

 

Description

  • Study participation will last about a year.  
  • Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).  
  • During the treatment period, the participants will visit the research center 9 times over a 48 week period.  
  • All participants will come back 6 weeks after the final study visit for a follow-up visit.

 

Study-related neuro-psychological evaluation, neurological and physical exams, laboratory tests, ECG, and brain scans are provided to research study participants at designated time points during screening and throughout the trial. As with all studies at the Memory Health Center, if you qualify for this research study all research related care, evaluations, study medication, and office visits will be provided at no cost. Insurance is not required for study participation and compensation may be available.

Details
Condition Dementia, Alzheimer's Disease
Clinical Study IdentifierTX226200
Last Modified on12 January 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note